Document Detail


The use of drugs and nutritional supplements in top-level track and field athletes.
MedLine Citation:
PMID:  19812387     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: High use of medication and nutritional supplements has been reported in several sports.
PURPOSE: To document the use of prescribed medication and nutritional supplements in female and male junior, youth, and adult track and field athletes depending on their sports discipline.
STUDY DESIGN: Descriptive epidemiology study.
METHODS: Analysis of 3 887 doping control forms undertaken during 12 International Association of Athletics Federations World Championships and 1 out-of-competitions season in track and field.
RESULTS: There were 6 523 nutritional supplements (1.7 per athlete) and 3 237 medications (0.8 per athlete) reported. Nonsteroidal anti-inflammatory drugs (NSAIDs; 0.27 per athlete, n = 884), respiratory drugs (0.21 per athlete, n = 682), and alternative analgesics (0.13, n = 423) were used most frequently. Medication use increased with age (0.33 to 0.87 per athlete) and decreased with increasing duration of the event (from sprints to endurance events; 1.0 to 0.63 per athlete). African and Asian track and field athletes reported using significantly fewer supplements (0.85 vs 1.93 per athlete) and medications (0.41 vs 0.96 per athlete) than athletes from other continents. The final ranking in the championships was unrelated to the quantity of reported medications or supplements taken. Compared with middle-distance and long-distance runners, athletes in power and sprint disciplines reported using more NSAIDs, creatine, and amino acids, and fewer antimicrobial agents.
CONCLUSION: The use of NSAIDs in track and field is less than that reported for team-sport events. However, nutritional supplements are used more than twice as often as they are in soccer and other multisport events; this inadvertently increases the risk of positive results of doping tests.
CLINICAL RELEVANCE: It is essential that an evidence-based approach to the prescribing of medication and nutritional supplements is adopted to protect the athletes' health and prevent them from testing positive in doping controls.
Authors:
Philippe Tscholl; Juan M Alonso; Gabriel Dollé; Astrid Junge; Jiri Dvorak
Related Documents :
16931617 - Inflammation as the key interface of the medical and nutrition universes: a provocative...
9437627 - Levo-alpha acetyl methadol (laam). its advantages and drawbacks.
1931377 - Medical causes of abnormal vaginal bleeding.
21413647 - Eponyms in leprology.
21516157 - Non ketotic hyperosmolar hyperglycemia presenting as epilepsia partialis continua: an u...
22098257 - Comparative cost analysis of housing and case management program for chronically ill ho...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-10-07
Journal Detail:
Title:  The American journal of sports medicine     Volume:  38     ISSN:  1552-3365     ISO Abbreviation:  Am J Sports Med     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-06     Completed Date:  2011-01-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7609541     Medline TA:  Am J Sports Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  133-40     Citation Subset:  IM    
Affiliation:
Fédération Internationale de Football Association (FIFA) Medical Assessment and Research Centre (F-MARC), Schulthess Klinik, Zurich, Switzerland. ph.tscholl@sunrise.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acids
Anti-Inflammatory Agents, Non-Steroidal
Athletic Performance
Confidence Intervals
Creatine
Dietary Supplements / statistics & numerical data,  utilization*
Doping in Sports*
Drug Prescriptions
Epidemiologic Studies
Female
Humans
Internationality
Male
Nutritional Status
Respiratory System Agents
Track and Field*
World Health
Chemical
Reg. No./Substance:
0/Amino Acids; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Respiratory System Agents; 57-00-1/Creatine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skelet...
Next Document:  Selective disruption of ER{alpha} DNA-binding activity alters uterine responsiveness to estradiol.